Market: NMS |
Currency: USD
Address: 22211 West Interstate 10
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
📈 bioAffinity Technologies, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for bioAffinity Technologies, Inc.
| Date | Reported EPS |
|---|
| 2025-11-14 | -4.74 |
| 2025-08-14 | -5.1 |
| 2025-08-14 | - |
| 2025-05-15 | -4.8 |
| 2025-03-31 | -6.3 |
| 2024-11-14 | -4.8 |
| 2024-08-14 | -5.7 |
📰 Related News & Research
No related articles found for "bioaffinity technologies".
